| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8688002 | NeuroImage: Clinical | 2018 | 37 Pages |
Abstract
This is the first study to show that variation in M1 receptors in the DLPFC is related to cognitive and negative symptom outcome in psychotic disorders. The M1 receptor may be an important biomarker in biological stratification of patients with psychotic disorders.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Geor Bakker, Claudia Vingerhoets, Daphne Boucherie, Matthan Caan, Oswald Bloemen, Jos Eersels, Jan Booij, Thérèse van Amelsvoort,